DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Drug: placebo
Drug: eszopiclone

First Posted Date: 2009-02-02

Last Posted Date: 2014-09-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT00833547

Locations: 🇺🇸
Mass General Hospital, Boston, Massachusetts, United States

Bone Mass Accrual in Adolescent Athletes

Phase 3

Withdrawn

Conditions: Bone Loss
Amenorrhea

Interventions: Drug: Estrogen

First Posted Date: 2009-01-22

Last Posted Date: 2021-10-26

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT00827151

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Omega-3 for Peri- and Postmenopausal Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Drug: Omega-3 Fatty Acids

First Posted Date: 2009-01-21

Last Posted Date: 2014-08-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 31

Registration Number: NCT00825994

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

Phase 2

Completed

Conditions: Rosacea

Interventions: Drug: Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel
Drug: Placebo gel

First Posted Date: 2009-01-16

Last Posted Date: 2012-06-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 83

Registration Number: NCT00823901

Locations: 🇺🇸
Department of Dermatology - Stanford School of Medicine, Stanford, California, United States
🇺🇸
CURTIS - Massachussetts General Hospital, Boston, Massachusetts, United States

Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life

Completed

Conditions: Psoriasis

First Posted Date: 2009-01-16

Last Posted Date: 2017-03-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 116

Registration Number: NCT00823914

Locations: 🇺🇸
Massachusetts General Hospital CURTIS, Boston, Massachusetts, United States

Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Escitalopram
Behavioral: Cognitive Behavioral Therapy (CBT)

First Posted Date: 2009-01-16

Last Posted Date: 2018-01-05

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 39

Registration Number: NCT00824044

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma

Phase 1

Completed

Conditions: Glioblastoma

Interventions: Drug: Sirolimus
Drug: Vandetanib

First Posted Date: 2009-01-13

Last Posted Date: 2015-05-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 33

Registration Number: NCT00821080

Locations: 🇺🇸
Dana-Farber Cancer Instiute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Infant Nutrition and Risk of Celiac Disease

Not Applicable

Terminated

Conditions: Celiac Disease
Infant Nutrition

Interventions: Dietary Supplement: Gluten
Dietary Supplement: Gluten free diet

First Posted Date: 2009-01-09

Last Posted Date: 2017-03-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 80

Registration Number: NCT00819819

Locations: 🇺🇸
Massachusetts General Hospital East, Charlestown, Massachusetts, United States

Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Phase 2

Terminated

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Lithium Carbonate
Drug: placebo
Drug: Riluzole

First Posted Date: 2009-01-07

Last Posted Date: 2011-04-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 84

Registration Number: NCT00818389

Locations: 🇺🇸
Cedars-Sinai ALS Center, Neurology Specialty Clinic, 8730 Alden Drive, Thalians, E 245, Los Angeles, California, United States
🇺🇸
Ohio State University, Neuromuscular Division, 1654 Uphan Drive, 417 Means Hall, Columbus, Ohio, United States
🇨🇦
University of Saskatchewan, Saskatoon City Hospital, 701 Queen Street, Room 7717 - 7th Floor, Saskatoon, Saskatchewan, Canada

and more 34 locations

Zolpidem CR and Hospitalized Patients With Dementia

Not Applicable

Completed

Conditions: Alzheimer Disease
Sleep Disorders
Circadian Dysregulation
Dementia
Dementia, Vascular

Interventions: Drug: Zolpidem CR
Drug: Placebo

First Posted Date: 2008-12-25

Last Posted Date: 2017-05-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT00814502

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy